We are live on
!
Find out more
FGAM
Financial Gravity Asset Management Portfolio holdings
AUM
$562M
This Fund
S&P 500
This Quarter
Est. Return
-0.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.7M
AUM Growth
–
Cap. Flow
+$100M
Cap. Flow
% of AUM
102.32%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
1,580
New
1,577
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.02% |
| 2 | Healthcare | 9.95% |
| 3 | Technology | 8.4% |
| 4 | Industrials | 5.02% |
| 5 | Financials | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nomad Foods
NOMD
$1.53B
| $225K | 0.23% |
+13,755
| New | +$227K |
|
77
Qualcomm
QCOM
$192B
| $224K | 0.23% |
+4,462
| New | +$284K |
|
78
DXC Technology
DXC
$1.82B
| $223K | 0.23% |
+2,541
| New | +$222K |
|
79
Microsoft
MSFT
$3.75T
| $221K | 0.23% |
+2,360
| New | +$216K |
|
80
Tyson Foods
TSN
$18.6B
| $219K | 0.22% |
+3,260
| New | +$249K |
|
81
Lear
LEA
$6.45B
| $213K | 0.22% |
+1,130
| New | +$213K |
|
82
Generac Holdings
GNRC
$11B
| $212K | 0.22% |
+4,684
| New | +$223K |
|
83
Regeneron Pharmaceuticals
REGN
$81.7B
| $211K | 0.22% |
+714
| New | +$248K |
|
|
ALXN
84
DELISTED
Alexion Pharmaceuticals
ALXN
| $211K | 0.22% |
+1,845
| New | +$221K |
|
85
CAE Inc
CAE
$7.83B
| $210K | 0.21% |
+11,274
| New | +$207K |
|
86
General Motors
GM
$76.5B
| $207K | 0.21% |
+5,721
| New | +$232K |
|
87
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.83B
| $207K | 0.21% |
+13,580
| New | +$208K |
|
88
Labcorp
LH
$25.6B
| $205K | 0.21% |
+1,399
| New | +$206K |
|
89
Mativ Holdings
MATV
$652M
| $205K | 0.21% |
+5,233
| New | +$222K |
|
90
HP
HPQ
$30.7B
| $204K | 0.21% |
+9,479
| New | +$214K |
|
91
Sonoco
SON
$4.78B
| $203K | 0.21% |
+3,961
| New | +$201K |
|
92
Nucor
NUE
$58.9B
| $198K | 0.2% |
+3,245
| New | +$215K |
|
|
ORAN
93
DELISTED
Orange
ORAN
| $198K | 0.2% |
+10,950
| New | +$190K |
|
|
VIAB
94
DELISTED
Viacom Inc. Class B
VIAB
| $197K | 0.2% |
+6,645
| New | +$215K |
|
95
BioMarin Pharmaceuticals
BMRN
$12.9B
| $195K | 0.2% |
+2,367
| New | +$203K |
|
96
Raymond James Financial
RJF
$33.4B
| $194K | 0.2% |
+3,299
| New | +$205K |
|
97
Illumina
ILMN
$31.4B
| $193K | 0.2% |
+827
| New | +$190K |
|
98
State Street
STT
$53.1B
| $193K | 0.2% |
+1,978
| New | +$207K |
|
99
Jazz Pharmaceuticals
JAZZ
$16B
| $192K | 0.2% |
+1,271
| New | +$186K |
|
100
McCormick & Company Non-Voting
MKC
$13.5B
| $192K | 0.2% |
+3,790
| New | +$199K |
|
Similar funds
AIM
PFG
TM
JHCP
OWM
DCM
FFWA
BFIC
Financial Gravity Asset Management's Q1 2018 Portfolio in Review
Q1 2018 is the first quarter with a 13F filing on record for Financial Gravity Asset Management, which disclosed 1,580 positions worth $97.7M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is State Street SPDR S&P MIDCAP 400 ETF Trust: 21,371 shares worth $7.29M.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, followed by Healthcare and Technology.
- Financial Gravity Asset Management's largest Q1 2018 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 21,371 shares worth $7.29M.
- Financial Gravity Asset Management's ten largest holdings make up 30% of its $97.7M portfolio in Q1 2018.
- Financial Gravity Asset Management disclosed 1,580 positions in Q1 2018, its first 13F filing on record.
Based on Financial Gravity Asset Management's 13F filing for Q1 2018, filed 23 May 2018.